Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Sudlow, Cathie L M ^a   Mason, Gillian ^b   Maurice, James B ^c   Wedderburn, Catherine J ^c   Hankey, Graeme J ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MAROONDAH HOSPITAL   (Australia)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Aspirin *therapeutic use ; Cardiovascular diseases *prevention control ; Humans; Myocardial infarction prevention control ; Platelet aggregation inhibitors *therapeutic use ; Randomized controlled trials as topic; Stroke prevention control ; Ticlopidine analogs derivatives; *therapeutic use

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE;

ALLERGY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INDIGESTION; NAUSEA; NEUTROPENIA; PROPHYLAXIS; RASH; REVIEW; STROKE; THROMBOCYTOPENIA; TRANSIENT ISCHEMIC ATTACK; VOMITING;

EID: 76449091888     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001246.pub2     Document Type: Review

References (77)

1. AAASPS {published data only} Gorelick PB, Richardson D, Kelly M, Ruland S, Hung E, Harris Y, et al.Aspirin and ticlopidine for prevention of recurrent stroke in black patients. A randomised trial. JAMA 2003;289(22):2947-57.
2. CAPRIE {published and unpublished data} CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
3. De Lucia 2000 {published data only} De Lucia D, Pezzella S, Maisto G, Del Giudice V, Lauretano M, Quartucci R, et al.Ticlopidine for patients on short-term incidence of ischemic stroke with high glycocalicin plasma levels. Journal of Neural Transmission 2000;107(5):42.
4. Japanese-B {published data only} Murakami G, Toyokura Y, Omae T. Effects of aspirin and ticlopidine on transient ischaemic attack. Sindan To Chiryo 1986; 74:2255-74.
5. Murakami M, Toyokura Y, Omae T, Gotoh F, Tazaki Y, Ohtomo E, et al.Effects of ticlopidine and aspirin on TIA - a twelve month, double blind comparative study. Igaku no Ayumi 1983;127(9): 950-71.
6. Tohgi H. L'etude japonaise de la ticlopidine dans les accidents ischemiques transitoires. Maladies Cerebrovasculaires 1990;April: 19-22.
7. Tohgi H. The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study. In: JL Gordon editor (s). Ticlopidine: Quo Vadis?. Vol. 15, Basel: Birkhauser Verlag, 1984:279-82.
8. Tohgi H. The Japanese ticlopidine study in transient ischaemic attacks. Sang Thrombose Vaisseaux 1990;2(4):19-22.
9. * Tohgi H, Murakami M. The effect of ticlopidine on TIA compared with aspirin - a double-blind, twelve-month and open 24-month follow-up study. Japanese Journal of Medicine 1987;26 (1):117-9.
10. Li 2000 {published data only} * Li Y, Li D, Wang L. A prospective randomized control study on ticlopidine with aspirin for the prevention of ischaemic cerebral stroke. Journal of Clinical Neurology 2000;13(3):146-8.
11. Li Y-Z, Wang L, Yu P-X. A randomized trial comparing ticlopidine with aspirin for the prevention of ischaemic cerebral stroke. Acta Pharmacologica Sinica 1999;20(5):476.
12. Sadowski 1995 {published data only} Sadowski Z, Kuczak D, Dyduszynski A, Giep L, Kalicinski A, Kraska T, et al.Comparison of ticlopidine and aspirin in unstable angina. European Heart Journal 1995;16 Suppl:259.
13. Schoop 1983 {unpublished data only} Schoop W. Open randomised study comparing ticlopidine with acetylsalicylic acid in the prevention of contralateral thrombosis in patients initially presenting with unilateral thrombosis. Guildford: Sanofi Winthrop (Sanofi internal report 001.6.174) 1983.
14. STAMI {published data only} Scrutinio D, Cimminiello C, Marubini E, Pitzalis MV, Di Biase M, Rizzon P. Ticlopidine versus aspirin after myocardial infarction (STAMI) trial. Journal of the American College of Cardiology 2001; 37(5):1259-65.
15. TASS {published data only} Hass WK, Easton JD, Adams HP, Pryse-Phillips W, Molony BA, Anderson S, et al.A randomised trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. New England Journal of Medicine 1989;321:501-7.
16. Zhu 2001 {published data only} Zhu L-S, Ding J-F, Bian J. Analyses of controlled trial of prevention against ischaemic stroke with different agents and dosage for patients recovering from cerebral infarction. Modern Rehabilitation 2001;5(1):55-6.
17. Abe 1981 {published data only} Abe T, Kuramoto A, Yasunaga K. Clinical evaluation of ticlopidine in the inhibition of platelet function: A multiclinic double-blind study in comparison with aspirin. Thrombosis & Haemostasis 1981; 46(1):1300.
18. Akyuz 1999 {published data only} Akyuz A, Bolayir E, Dener S, Topalkara K, Topaktas S. The effect of aspirin, ticlopidine and their low-dose combination on platelet aggregability in acute ischemic stroke: a short duration follow-up study. European Journal of Neurology 1999;6:57-61.
19. Apollonio 1989 {published data only} Apollonio A, Castignani P, Magrini L, Angeletti R. Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents. Journal of International Medical Research 1989;17:28- 35.
20. Aramendi 1998 {ublished data only} Aramendi JL, Agredo J, Llorente A, Larrarte C, Pijoan J. Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis. Journal of Heart Valve Disease 1998;7:610-4.
21. Bergamasco 1997 {published data only} Bergamasco B, Benna P, Carolei A, Rasura M, Rudelli G, Fieschi C, et al.A randomised trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS study). Functional Neurology 1997;12:33-43.
22. Cooke 2006 {published data only} Cooke GE, Liu-Stratton Y, Ferketich AK, Moeschberger ML, Frid DJ, Magorien RD, et al.Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination. Journal of the American College of Cardiology 2006;47:541-6.
23. Dorr 2004 {published data only} Dorr G, Schmidt G, Grafe M, Regitz-Zagrosek V, Fleck E. Effects of combined therapy with clopidogrel and acetylsalicylic acid on platelet glycoprotein expression and aggregation. Journal of Cardiovascular Pharmacology 2002;39(4):523-32.
24. Droste 1996 {published data only} * Droste DW, Siemans H-J, Sonne M, Kaps M, Wagner T. Hemostaseologic and hematologic parameters with aspirin and ticlopidine treatment in patients with cerebrovascular disease: a cross-over study. Journal of Cardiovascular Pharmacology 1996;28: 591-4.
25. Droste DW, Sonne M, Siemans H-J, Kaps M. Asymptomatic circulating cerebral emboli and cerebral blood flow velocity under aspirin and ticlopidine in patients with cerebrovascular disease. Neurological Research 1996;18:449-53.
26. Siemens A, Droste DW, Brueckner S, Sonne M, Koemp D, Wagner T. Differences in platelet aggregation in patients with cerebrovascular disease under ASA or ticlopidine. Thrombosis & Haemostasis 1995;73(6):954.
27. Eder 2007 {published data only} Eder C, Funke U, Schulze M, Lutze G, Zimmermann M, Prasse T, et al.Modified platelet aggregation test in patients on ASA and/or clopidogrel. Hamostaseologie 2007;27:163- 76.
28. Fork 2000 {published data only} Fork FT, Lafolie P, Toth E, Lindgarde F. Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study. Scandinavian Journal of Gastroenterology 2000; 35(5):464-69.
29. Jagroop 2004 {published data only} Jagroop IA, Matsagas MI, Geroulakos G, Mikhailidis DP. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease. Platelets 2004; 15(2):117-25.
30. Kindsvater 2003 {published data only} Kindsvater S, Leclerc K, Ward J. Effects of coadministration of aspirin or clopidogrel on exercise testing in patients with heart failure receiving angiotensin-converting enzyme inhibitors. American Journal of Cardiology 2003;91:1350-2.
31. KTS 1999 {published data only} Chen WH, Lan MY, Peng MC, Wu SS, Ngai WK, Chang YY, et al.The Kaohsiung Medical College Hospital Ticlopidine Study (KTS): a five-year prospective study to follow the outcome and complication of ticlopidine hydrochloride in Taiwanese. Acta Neurologica Taiwanica 1999;8(2):126.
32. Lim 2004 {published data only} Lim E, Cornelissen J, Routledge T, Kirtland S, Charman SC, Bellm S, et al.Clopidogrel did not inhibit platelet function early after coronary bypass surgery: a prospective randomized trial. Journal of Thoracic & Cardiovascular Surgery 2004;128(3):432-35.
33. Nomura 1996 {published data only} Nomura H, Morita C, Kuwano S, Eto H, Goto H, Kuwahara H. Efficacy of combination antiplatelet therapy and nicardipine for chronic cerebral infarction. Clinical Therapeutics 1996;18(3): 483-9.
34. Ozalp 1997 {published data only} * Ozalp K, Erdogan N, Tunali F, Misirli H, Erenoglu NY. Effect of ticlopidine and aspirin on plasma fibrinogen level. Cerebrovascular Diseases 1997;7 Suppl 4:53.
35. Ozalp K, Erdogan N, Tunali F, Misirli H, Erenoglu NY. Effect of ticlopidine and aspirin on plasma fibrinogen level. European Journal of Neurology 1997;4 Suppl 1:S119-20.
36. Rebrov 2001 {published data only} Rebrov AP, Voskoboi IV. Comparative efficacy of tiklid and aspirin in patients with unstable angina. Terapevticheskii Arkhiv 2001;73 (12):25-9.
37. Rey 1996 {published data only} Rey A, Aguilar M, Bonaventura I, Martinez I, Quintana S. Antiaggregant treatment for cerebral ischemia: ticlopidine versus aspirin. Revista de Neurologia 1996;24(126):214-8.
38. Rupprecht 1998 {published data only} Rupprecht HJ, Darius H, Borkowski U, Voigtländer T, Nowak B, Genth S, et al.Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation. Circulation 1998;97:1046-52.
39. Singh 1999 {published data only} Singh P, Kar AM, Nag D, Misra A, Shukla R, Agarwal A, et al.Effect of aspirin and ticlopidine, alone or combined, on platelet aggregation in acute ischaemic stroke. Journal of Internal Medicine of India 1999;2:300-4.
40. Tokyo 1993 {unpublished data only} Uchiyama S. Safety and efficacy of ticlopidine alone or with aspirin in patients with cerebral infarction or TIA. Unpublished 1993.
41. Vyshlov 2000 {published data only} Vyshlov EV, Panfilova EV, Markov VA. Aspirin vs ticlid and their combination in patients with acute myocardial infarction. Klinicheskaia Meditsina 2000;78:37-9.
42. Woodward 2004 {published data only} Woodward M, Lowe GDO, Francis LMA, Rumley A, Cobbe SM, Bain R, et al.Randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the CADET trial. Journal of Thrombosis & Haemostasis 2004;2(11):1934-40.
43. Zucca 1992 {published data only} Zucca R, Farina M, Basellini A, Bonalumi FA, Dellavedova M. Evaluation of ASA and ticlopidine treatment to prevent carotid restenosis after carotid TEA. Preliminary report. Proceedings of the 16th World Congress of the International Union of Angiology. 1992:338.
44. Bokarev 1998 {published data only} Bokarev IN, Aksenova MB, Khlevchuk TV, Dovgolis SA. Effectiveness of unstable angina pectoris treatment by aggregation inhibitors ticlid and aspirin. KlinicheskaiaMeditsina 1998;76: 49-52.
45. WATCH {published data only} Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, et al.Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation 2009;119:1559-61.
46. ASCET {published data only} Pettersen AA, Seljeflot I, Abdelnoor M, Arnesen H. Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design. Scandinavian Cardiovascular Journal 2004;38:353-6.
47. APT 1994 Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
48. ATT 2002 Antithrombotic Trialists' Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
49. Bennett 1999 Bennett CL, Davidson CJ, Raisch DW. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention. Archives of Internal Medicine 1999;159:2524-8.
50. Bertrand 2000 Bertrand ME, Rupprecht H-J, Urban P, Gershlick AH, for the CLASSICS Investigators. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting. Circulation 2000;102:624-9.
51. BNF 2008 British National Formulary. http://www.bnf.org/bnf/ September 2008.
52. CARESS Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, et al.Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005;111:2233-40.
53. Chan 2005 Chan FKL, Ching JYL, Hung LCT, Wong VWS, Leun VKS, Kung NNS, et al.Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. New England Journal of Medicine 2005; 352(3):238-44.
54. CHARISMA 2006 Bhatt DL, Fox KA, HackeW, Berger PB, Black HR, Boden WE, et al.Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. New England Journal of Medicine 2006; 354:1706-17.
55. ESPRIT The ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006;367:1665-73.
56. ESPS-2 Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European secondary prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. Journal of Neurological Sciences 1996;143:1-13.
57. FASTER Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM, FASTER Investigators. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurology 2007;6:961-9.
58. Hebert 1993 Hebert JM, Frechel D, Vallee E. Clopidogrel, a novel antiplatelet and antithrombotic agent. Cardiovascular Drug Reviews 1993;11: 180-93.
59. Ho 2009 Ho PM, Maddox TM,Wang L, Fihn SD, Jesse RL, Peterson ED, et al.Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009;301:937-44.
60. Lanas 2007 Lanas A, García-Rodríguez L, Arroyo MT, Bujanda L, Gomollón F, Forné M, et al.Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. American Journal of Gastroenterology 2007;102:507-15.
61. MATCH 2004 Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al.Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebocontrolled trial. Lancet 2004;364:331-7.
62. McTavish 1990 McTavish D, Faulds G, Goa KL. Ticlopidine: an updated review of its pharmacology and therapeutic use in platelet-dependent disorders. Drugs 1990;40:238-59.
63. Moloney 1993 Moloney BA. An analysis of the side effects of ticlopidine.. In: Hass WK, Easton JD editor(s). Ticlopidine, Platelets and Vascular Disease. New York: Springer, 1993:117-39.
64. Müller 2000 Müller C, Büttner HJ, Petersen J, Roskamm H. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 2000; 101:590-3.
65. NICE Guidelines National Institute for Health and Clinical Excellence. Technology Appraisal 90: Clopidogrel and modified-release dipyridamole in the prevention of occlusive vascular events. http://www.nice.org.uk/ nicemedia/pdf/TA090guidance.pdf 2005.
66. Patrono 1989 Patrono C. Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back. Trends in Pharmacological Sciences 1989;10:453-8.
67. Patrono 1994 Patrono C. Aspirin as an antiplatelet drug. New England Journal of Medicine 1994;330:1287-94.
68. PRoFESS Sacco RL, Diener H-C, Yusuf S, Cotton D, unpuu S, Lawton WA, et al.Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. New England Journal of Medicine 2008;358: 1238-51.
69. PRoFESS Editorial Kent DM, Thaler DE. Stroke prevention - insights from incoherence. New England Journal of Medicine 2008;359:1287- 9.
70. RCP Guidelines Royal College of Physicians Intercollegiate Stroke Working Party. National Clinical Guidelines for Stroke. 3rd Edition. London: Clinical Effectiveness and Evaluation Unit, Royal College of Physicians, 2008.
71. Sabatine 2005 Sabatine MS. Something old, something new: beta blockers and clopidogrel in acute myocardial infarction. Lancet 2005;366: 1587-9.
72. SIGN Guidelines Scottish Intercollegiate Guidelines Network. Guideline 108. Management of patients with stroke or TIA: assessment, investigation, immediate management and secondary prevention. http://www.sign.ac.uk/pdf/sign108.pdf 2008.
73. Steinhubl 1999 Steinhubl SR, Tan WA, Foody JM, Topol EJ, for the EPISTENT Investigators. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. JAMA 1999;281:806-10.
74. Torok 1995 Torok TJ, Holman RC, Chorba TL. Increasing mortality from thrombotic thrombocytopenic purpura in the United States: analysis of national mortality data, 1968-1991. American Journal of Haematology 1995;50:84-90.
75. TRITON-TIMI 38 2007 Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al.Prasugrel versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine 2007; 357:2001-15.
76. Zakarija 2004 Zakarija A, Bandarenko N, Pandey DK, Auerbach A, Raisch DW, Kim B, et al.Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke 2004;35:533-7.
77. Hankey 2000 Hankey G, Sudlow CLM, Dunbabin DW. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. Cochrane Database of Systematic Reviews 2000, Issue 1. [Art. No.: CD001246. DOI: 10.1002/14651858.CD001246]